GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

The integration of Artificial Intelligence (AI) in drug discovery is rapidly transforming the pharmaceutical industry. Traditional drug development is a long, c ...

UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

Medicine has always demanded speed, accuracy, and compassion, but physicians in 2025 face greater challenges than ever before ...

As per Vantage Market Research, the Global Artificial Intelligence in the Drug Discovery Market has been steadily growing ...

DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines.

Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ...

D-Wave and Japan Tobacco's pharmaceutical division completed a proof-of-concept project aimed at speeding up and improving the design of ...

Ex-Google CEO Eric Schmidt warns AI could surpass human control by 2026. Discover the risks and opportunities of artificial ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to ...

The global AI-enabled drug discovery and clinical trials market size is estimated to reach USD 1,599 by 2030 from 2019 with a CAGR of 24%. The clinical guidelines are not uniform across the studied ...

Eli Lilly has signed a new research deal with BigHat Biosciences to co-develop next-generation antibody therapeutics, as the ...